Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00226174 · ClinicalTrials.gov registry record · Phase 2
A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00226174 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco.
The verdict
NCT00226174, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine whether curcuminoids are effective in the treatment of oral lichen planus.
Interventions
- DRUG Curcuminoids
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00226174
The ClinicalTrials.gov registry entry for NCT00226174 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Curcuminoids is the first listed.
NCT00226174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00226174 about?
NCT00226174 is a clinical study titled "A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus". The purpose of this study is to determine whether curcuminoids are effective in the treatment of oral lichen planus.
What is the current status of trial NCT00226174?
This trial is currently terminated. It is a Phase 2 study. The study started on 2003-02. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00226174?
The interventions under investigation include: Curcuminoids (DRUG).
Who is sponsoring clinical trial NCT00226174?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.